226 related articles for article (PubMed ID: 36196569)
1. Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Saifuddin A; Kent AJ; Mehta SJ; Hicks LC; Gonzalez HA; Segal JP; Brookes MJ; Subramanian S; Bhala N; Conley TE; Patel KV; ; Lamb CA; Walker GJ; Kennedy NA; Sebastian S
Aliment Pharmacol Ther; 2022 Nov; 56(10):1460-1474. PubMed ID: 36196569
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
Nørgård BM; Zegers FD; Nielsen J; Knudsen T; Kjeldsen J
Inflamm Bowel Dis; 2023 Sep; 29(9):1470-1476. PubMed ID: 37067508
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Disease Phenotype and Course among Elderly- and Early-Onset Inflammatory Bowel Diseases in the Middle East.
Vosoghinia H; Saberzadeh-Ardestani B; Anushiravani A; Mansour-Ghanaei F; Fakheri H; Vahedi H; Sheikhesmaeili F; Yazdanbod A; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Malekzadeh M; Kasaeian A; Alatab S; Sadeghi A; Kolahdoozan S; Amani M; Saberhosseini SN; Rayatpisheh M; Ahadi M; Colombel JF; Ungaro RC; Sima AR; Malekzadeh R
Arch Iran Med; 2023 Sep; 26(9):481-488. PubMed ID: 38310403
[TBL] [Abstract][Full Text] [Related]
4. Disease Flares Following COVID-19 Vaccination in Patients with Inflammatory Bowel Disease.
Yoshida Y; Fujioka S; Moriyama T; Umeno J; Kawasaki K; Fuyuno Y; Matsuno Y; Ihara Y; Torisu T; Kitazono T
Intern Med; 2023 Dec; 62(24):3579-3584. PubMed ID: 37779068
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
[TBL] [Abstract][Full Text] [Related]
6. Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn's disease in Japan.
Miyazaki H; Watanabe D; Ito Y; Ikeda S; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
Indian J Gastroenterol; 2023 Oct; 42(5):701-707. PubMed ID: 37505394
[TBL] [Abstract][Full Text] [Related]
7. Is Vaccination Against COVID-19 Associated With Inflammatory Bowel Disease Flare? Self-Controlled Case Series Analysis Using the UK CPRD.
Card TR; Nakafero G; Grainge MJ; Mallen CD; Van-Tam JSN; Williams HC; Abhishek A
Am J Gastroenterol; 2023 Aug; 118(8):1388-1394. PubMed ID: 36826512
[TBL] [Abstract][Full Text] [Related]
8. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
9. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
10. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
Atia O; Shavit-Brunschwig Z; Mould DR; Stein R; Matar M; Aloi M; Ledder O; Focht G; Urlep D; Hyams J; Broide E; Weiss B; Levine J; Russell RK; Turner D
Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):31-42. PubMed ID: 36306803
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview.
M'Koma AE
Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35629984
[TBL] [Abstract][Full Text] [Related]
12. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.
Barré A; Colombel JF; Ungaro R
Aliment Pharmacol Ther; 2018 Apr; 47(7):896-905. PubMed ID: 29430672
[TBL] [Abstract][Full Text] [Related]
13. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of factors that trigger inflammatory bowel disease flares.
Feagins LA; Iqbal R; Spechler SJ
World J Gastroenterol; 2014 Apr; 20(15):4329-34. PubMed ID: 24764669
[TBL] [Abstract][Full Text] [Related]
15. The change of healthcare service in Chinese patients with inflammatory bowel disease during the pandemic: a national multicenter cross-sectional study.
Li X; Wang F; Jia Y; Zhou H; Shi Y; Tian F; Chen Y; Liang J
Sci Rep; 2023 Nov; 13(1):20084. PubMed ID: 37973924
[TBL] [Abstract][Full Text] [Related]
16. The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.
Deputy M; Sahnan K; Worley G; Patel K; Balinskaite V; Bottle A; Aylin P; Burns EM; Hart A; Faiz O
Aliment Pharmacol Ther; 2022 Apr; 55(7):836-846. PubMed ID: 35132663
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis.
Lee MH; Li HJ; Wasuwanich P; Kim SE; Kim JY; Jeong GH; Park S; Yang JW; Kim MS; Yon DK; Lee SW; Koyanagi A; Jacob L; Kim EY; Cheon JH; Shin JI; Smith L
Rev Med Virol; 2023 Mar; 33(2):e2414. PubMed ID: 36504172
[TBL] [Abstract][Full Text] [Related]
18. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study.
Sáiz-Chumillas RM; Barrio J; Fernández-Salazar L; Arias L; Sierra Ausín M; Piñero C; Fuentes Coronel A; Mata L; Vásquez M; Carbajo A; Alcaide N; Cano N; Nuñez A; Fradejas P; Ibáñez M; Hernández L; Sicilia B
Gastroenterol Hepatol; 2023 Feb; 46(2):102-108. PubMed ID: 35569540
[TBL] [Abstract][Full Text] [Related]
19. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
Bolge SC; Waters H; Piech CT
Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab.
Hu A; Kotze PG; Burgevin A; Tan W; Jess A; Li PS; Kroeker K; Halloran B; Panaccione R; Peyrin-Biroulet L; Ma C; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1366-1376.e2. PubMed ID: 32668338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
